Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma

Cancer incidence, mortality and prevalence worldwide

J Ferlay · Medical Entomology and Zoology · 2004 · 3.8K citations

Medicine, Oncology, Cancer Epidemiology +13

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

Markus Guba, Philipp von Breitenbuch, Markus Steinbauer et al. · Nature Medicine · 2002 · 1.7K citations

Medicine, Oncology, Pharmacology +16

Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa, Lawrence H. Schwartz, Sergio Ricci et al. · Journal of Clinical Oncology · 2006 · 1.2K citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

Ricky T. Tong, Yves Boucher, Sergey V. Kozin et al. · Cancer Research · 2004 · 1.2K citations · Full text

Medicine, Cancer Biology, Oncology +17

Cyclosporine induces cancer progression by a cell-autonomous mechanism

Minoru Hojo, Takashi Morimoto, Mary A. Maluccio et al. · Nature · 1999 · 1.2K citations

Medicine, Oncology, Pharmacology +11